Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 104 of 151

  1. Placebo

    NovaBridge Biosciences

    Breast Cancer

    phase 2 small molecule terminated

    1 trial

  2. Placebo

    Sarepta Therapeutics

    Duchenne Muscular Dystrophy

    phase 2 small molecule completed

    1 trial

  3. Placebo

    United Therapeutics Europe Ltd

    Influenza

    phase 2 small molecule completed

    1 trial

  4. Placebo

    Jazz Pharmaceuticals Ireland Limited

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  5. Placebo

    MapLight Therapeutics

    Schizophrenia

    phase 2 small molecule active

    1 trial

  6. Placebo

    Alnylam Netherlands B.V.

    Hypertension

    phase 2 small molecule completed

    1 trial

  7. Placebo

    LEXICON PHARMACEUTICALS, INC.

    Postherpetic Neuralgia

    phase 2 small molecule completed

    1 trial

  8. Placebo

    Teva Pharma GmbH

    Primary Progressive Multiple Sclerosis

    phase 2 small molecule completed

    1 trial

  9. Placebo

    Theravance Biopharma Ireland Umited

    Chronic Obstructive Pulmonary Disease, COPD

    phase 2 small molecule completed

    1 trial

  10. Placebo

    Theravance Biopharma Ireland Umited

    Crohn's Disease

    phase 2 small molecule terminated

    1 trial

  11. Placebo

    Vistagen Therapeutics

    Healthy

    phase 2 small molecule completed

    1 trial

  12. Placebo

    Takeda

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  13. Placebo

    Takeda

    Primary Immune Thrombocytopenia

    phase 2 small molecule completed

    1 trial

  14. Placebo

    Takeda

    Narcolepsy Type 2

    phase 2 small molecule completed

    1 trial

  15. Placebo

    Takeda

    Essential Hypertension

    phase 2 small molecule completed

    1 trial

  16. Placebo

    Takeda

    Endometriosis

    phase 2 small molecule completed

    2 trials

  17. Placebo

    Takeda

    Celiac Disease

    phase 2 small molecule completed

    1 trial

  18. Placebo

    Takeda

    Graft Rejection

    phase 2 mab completed

    1 trial

  19. Placebo

    Takeda

    Gout

    phase 2 small molecule completed

    1 trial

  20. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Addiction

    phase 2 small molecule completed

    1 trial

  21. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Bipolar Depression

    phase 2 small molecule terminated

    1 trial

  22. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 2 small molecule active

    1 trial

  23. Placebo

    Universal Integrated

    Purpura, Schoenlein-Henoch

    phase 2 small molecule active

    1 trial

  24. Placebo

    Ars Pharmaceuticals Irl Limited

    Urticaria Chronic

    phase 2 small molecule active

    1 trial

  25. Placebo

    Regeneron UK Limited

    Asthma

    phase 2 small molecule completed

    1 trial

  26. Placebo

    Regeneron UK Limited

    Generalized Lipodystrophy

    phase 2 small molecule completed

    1 trial

  27. Placebo

    Vertex Pharmaceuticals (Australia) Pty.

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

  28. Placebo

    BRIGHT MINDS BIOSCIENCES INC.

    Methamphetamine Dependence

    phase 2 small molecule completed

    2 trials

  29. Placebo

    Acadia Pharmaceuticals B.V.

    Anxiety

    phase 2 small molecule active

    1 trial

  30. Placebo

    WINDTREE THERAPEUTICS INC /DE/

    Acute Decompensated Heart Failure

    phase 2 small molecule completed

    1 trial

  31. Placebo

    Advanz Pharma Limited

    Atrial Fibrillation

    phase 2 small molecule completed

    1 trial

  32. Placebo

    Janssen Cilag International NV

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  33. Placebo

    RIGEL PHARMACEUTICALS INC

    Asthma

    phase 2 small molecule completed

    1 trial

  34. Placebo

    Biotech Pharmaceutical Co.,

    Hemophilic Arthropathy

    phase 2 small molecule completed

    1 trial

  35. Placebo

    Hospital Authority, Hong Kong

    STOMACH NEOPLASM

    phase 2 small molecule active

    1 trial

  36. Placebo

    MedImmune

    Asthma

    phase 2 small molecule completed

    1 trial

  37. Placebo

    Lacuna Pharma Pty Ltd

    Severe Alcohol-Associated Hepatitis

    phase 2 small molecule active

    1 trial

  38. Placebo

    Spero Therapeutics

    Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

    phase 2 small molecule completed

    1 trial

  39. Placebo

    Cardiff Oncology

    Tuberous Sclerosis

    phase 2 small molecule active

    1 trial

  40. Placebo

    Serono Europe Limited

    Systemic Lupus Erythematosus

    phase 2 small molecule terminated

    1 trial

  41. Placebo

    Hoffmann-La Roche

    Diabetes Mellitus Type 2

    phase 2 small molecule completed

    1 trial

  42. Placebo (blinded)

    LEXICON PHARMACEUTICALS, INC.

    Diabetic Peripheral Neuropathic Pain

    phase 2 small molecule completed

    1 trial

  43. Placebo (for dupilumab)

    Regeneron UK Limited

    Nasal Polyps

    phase 2 small molecule completed

    1 trial

  44. Placebo (matched to VX-121 suspension)

    Vertex Pharmaceuticals (Australia) Pty.

    Cystic Fibrosis

    phase 2 small molecule completed

    1 trial

  45. Placebo + Inactive Marijuana (0% THC)

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Use

    phase 2 small molecule completed

    1 trial

  46. Placebo Infusion

    United Therapeutics Europe Ltd

    Brain Injuries, Traumatic

    phase 2 mab active

    1 trial

  47. Placebo Oral Tablet

    Mereo BioPharma Group plc

    Alpha 1-Antitrypsin Deficiency

    phase 2 small molecule completed

    1 trial

  48. Placebo capsule

    Ipsen

    Fibrodysplasia Ossificans Progressiva

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.